Marco Meglio, Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at email@example.com
Lewy Body Dementia Drug Neflamapimod Wins Fast Track Designation From FDA
EIP Pharma also announced results from the REVERSE-SD study that examined neflamapimod in early stage Alzheimer disease.
ROSA Neurosurgery Device Recalled Due to Software Issue
The robotic platform used in various neurosurgeries was identified for a class 1 recall due to a software error which can lead to robotic arm malfunction.
Roche Discontinues Trial of Duchenne Muscular Dystrophy Drug RG6206
The phase 2/3 trials will end after a futility analysis suggested that the drug is not likely to show a clinical benefit.
Taking Telemedicine to the Next Level: Cleveland Clinic Epilepsy Center
Imad Najm, MD, details how advanced telemedicine technology has created a paradigm shift in the way physicians see and treat patients at Cleveland Clinic and around the world.
Proposed Chronic Migraine Criteria Would Significantly Increase Patient Population
Data show patients with high frequency episodic migraine are comparable to those with chronic migraine in regard to chronicity and disability.
Satralizumab BLA Accepted by FDA for Treatment of NMOSD
Study data demonstrates that treatment with satralizumab reduces risk of relapses in patients with neuromyelitis optica spectrum disorder.
Liquid Celecoxib Reduces Acute Migraine Pain, Bothersome Symptoms
A phase 3 study of celecoxib oral solution showed statistically significant improvements in the acute treatment of episodic migraine.
Intranasal Diazepam Safe, Tolerable in Pediatric Epilepsy
Analysis of long-term safety of intranasal diazepam shows favorable results in children and adolescents with cluster or acute, repetitive seizures.
Deflazacort Superior to Prednisone for Treatment of Duchenne Muscular Dystrophy
Study results show that deflazacort tops prednisone across multiple checkpoints in patients with Duchenne muscular dystrophy.
New Assessment May Better Screen Adolescents With Epilepsy for Adult Transition
Epilepsy-specific TRAQ questionnaire shows high validity in pediatric epilepsy patients transitioning to adult epilepsy care.
Botox Gains FDA Approval for Lower Limb Spasticity in Pediatric Patients
The drug is now approved to treat pediatric patients with both upper and lower limb spasticity, excluding spasticity caused by cerebral palsy.
Botox Improves Gait, Pain in Pediatric Patients With Lower Limb Spasticity
The drug recently gained FDA approval for treatment of lower limb spasticity in pediatric patients without cerebral palsy, in which it is associated with improved functional outcomes.
Fenfluramine Reduces Frequency of TC Seizures in Dravet Syndrome
A pooled analysis of 2 phase 3 trials of fenfluramine demonstrate the clinical potential of the drug for patients with Dravet syndrome.
Status Epilepticus Drug Ganaxolone Shows Benefit in Refractory Seizures
Ganaxolone proves effective in phase 2 trial in patients with status epilepticus, with a median time to status cessation of 5 minutes.
New Grant Provides Research Opportunities for FTLD
Partnership between NIH and NINDS hopes to identify disease biomarkers and spur new clinical trials for frontotemporal lobar degeneration.
New ALS Research Emerges With Launch of Trials, Partnerships
New trials and research partnerships have launched with hopes to find answers for the terminal disease.
Omaveloxolone Shows Promise in Friedreich's Ataxia
Results of a phase 2 trial in patients with Friedreich’s ataxia leaves hope for the future, with regulatory submission on the agenda.
2 Clarke Drive Cranbury, NJ 08512